文献速递慢阻肺

COPD急性加重风险分层算法的泛化性

Generalizability of Risk Stratification Algorithms for Exacerbations in COPD.
PubMed 文献 · Chest · 2022-12-09

本研究利用SUMMIT(N=2,421,年风险0.22)、LOTT(N=595,年风险0.38)和TORCH(N=1,091,年风险0.52)三项研究数据,比较ACCEPT和Bertens两种预测模型与仅用急性加重史在预测未来12个月急性加重中的表现。结果显示预测模型AUC优于加重史,但临床效用因人群而异,且需针对具体场景重新校准才能提升临床效用。

要点

  • ACCEPT在三个样本中AUC均优于加重史,变化为0.08、0.07、0.10(P≤.001)。
  • Bertens在SUMMIT和TORCH中AUC优于加重史(变化0.10和0.05,P<.001),LOTT中未显优势。
  • 所有算法均存在净获益低于不进行风险分层的危害风险,重新校准后预测模型的危害风险大幅降低。

核心结论

  • 仅用急性加重史在所有场景中不太可能提供临床效用,且可能带来危害风险。
  • 预测模型预测性能更优,但需针对具体场景重新校准才能获得更高临床效用。

研究设计与样本

  • 研究设计为利用三项临床研究数据比较三种风险分层算法预测未来12个月急性加重的性能。
  • SUMMIT研究N=2,421,年风险0.22;LOTT研究N=595,年风险0.38;TORCH研究N=1,091,年风险0.52。

主要发现

  • ACCEPT在SUMMIT、LOTT和TORCH中AUC变化分别为0.08、0.07和0.10,均优于加重史(P≤.001)。
  • Bertens在SUMMIT和TORCH中AUC变化分别为0.10和0.05,优于加重史(P<.001),但在LOTT中未显优势。
  • 没有任何算法在所有样本中临床效用均最优。
  • 重新校准前,Bertens模型在低风险场景中通常优于其他算法,而ACCEPT在高风险场景中表现更优。
  • 所有三种算法均显示危害风险(净获益低于不进行任何风险分层),重新校准后两种预测模型的危害风险大幅降低。

临床怎么用

  • 临床选择COPD急性加重风险分层工具时需考虑所在人群的风险水平,并优先使用经本地校准的预测模型。

局限性

  • 研究仅基于三项临床试验数据,未涵盖所有真实世界人群。
  • 未报告模型重新校准的具体方法及外部验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Contemporary management of COPD relies on exacerbation history to risk-stratify patients for future exacerbations. Multivariable prediction models can improve the performance of risk stratification. However, the clinical utility of risk stratification can vary from one population to another. RESEARCH QUESTION: How do two validated exacerbation risk prediction models (Acute COPD Exacerbation Prediction Tool [ACCEPT] and the Bertens model) compared with exacerbation history alone perform in different patient populations? STUDY DESIGN AND METHODS: We used data from three clinical studies representing populations at different levels of moderate to severe exacerbation risk: the Study to Understand Mortality and Morbidity in COPD (SUMMIT; N = 2,421; annual risk, 0.22), the Long-term Oxygen Treatment Trial (LOTT; N = 595; annual risk, 0.38), and Towards a Revolution in COPD Health (TORCH; N = 1,091; annual risk, 0.52). We compared the area under the receiver operating characteristic curve (AUC) and net benefit (measure of clinical utility) among three risk stratification algorithms for predicting exacerbations in the next 12 months. We also evaluated the effect of model recalibration on clinical utility. RESULTS: Compared with exacerbation history, ACCEPT showed better performance in all three samples (change in AUC, 0.08, 0.07, and 0.10, in SUMMIT, LOTT, and TORCH, respectively; P ≤ .001 for all). The Bertens model showed better performance compared with exacerbation history in SUMMIT and TORCH (change in AUC, 0.10 and 0.05, respectively; P < .001 for both), but not in LOTT. No algorithm was superior in clinical utility across all samples. Before recalibration, the Bertens model generally outperformed the other algorithms in low-risk settings, whereas ACCEPT outperformed others in high-risk settings. All three algorithms showed the risk of harm (providing lower net benefit than not using any risk stratification). After recalibration, risk of harm was mitigated substantially for both prediction models. INTERPRETATION: Exacerbation history alone is unlikely to provide clinical utility for predicting COPD exacerbations in all settings and could be associated with a risk of harm. Prediction models have superior predictive performance, but require setting-specific recalibration to confer higher clinical utility.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ho, Safari, Adibi, et al. Generalizability of Risk Stratification Algorithms for Exacerbations in COPD. Chest. 2022. PMID: 36509123. doi:10.1016/j.chest.2022.11.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。